Published in

Taylor and Francis Group, Leukemia & Lymphoma, 1(64), p. 107-118, 2022

DOI: 10.1080/10428194.2022.2140281

Links

Tools

Export citation

Search in Google Scholar

A multi-center analysis of the impact of DA-EPOCH-R dose-adjustment on clinical outcomes of patients with double/triple-hit lymphoma

Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO